Advanced Oncotherapy Share Discussion Threads

[mrtruth1] 01/10/2017 12:23

It won't go belly up.

[wi1l] 01/10/2017 12:06

Significantly it seems that four of the main BOD have already positioned themselves protecting their own interests. If anyone is interested see page 39 of last years annual accounts and the bit about the £6.5m loan from Blackfinch which covers the lease and equipment as security. Although I am not sure I completely understand the wording, but it looks as though if the agreement with Blackfinch is broken then they step in as guarantees and honour the agreement and get the assets in return although it only mentions the lease which has somewhat confused me as I would have thought it would also include the LIGHT system equipment. Someone better versed might be able to throw more "light" on the implications but as I have said previously the main people with the most to lose will be formulating plans B,C &D should everything go belly up.

[ileeman] 01/10/2017 10:45

Chart broken major resistance, dont think it is out of the question to see 30p+ over next week or so.


free stock charts from uk.advfn.com

[daijavu] 01/10/2017 10:26

johnjohntaylor.

We shall see.

[daijavu] 01/10/2017 10:22

dave4545

AVO's chart has had that shape before. Then collapsed without fulfilling its promise.

[johnjohntaylor] 01/10/2017 10:17

Maybe they simply got too ahead of themselves (there's always two sides to a coin in life). All on target now, more realistic, more open, more informed and most importantly,much further down the line of development so the position is, of course, much stronger. It will work out I have NO doubt but it's up to you where your faith lies in share dealing.

[dave4545] 01/10/2017 10:11

Love it or hate it the chart looks a perfect short term bowl to 30p and maybe more
on the one year chart.

[daijavu] 01/10/2017 10:02

Some of us are experienced investors in the stockmarket who have considerable knowledge of the provenance and potential of LIGHT, the proton therapy market and AVO's competitors. Everything makes for a wonderful story.

The only thing that lets it down is AVO itself and the unfortunate track record that the management has of misleading shareholders and potential customers and reneging on contracts.

In late 2014 AVO issued a schedule that forecast that the LIGHT machine would be fully operational by the end of 2016 and the first patient would be treated by late 2017.

Despite numerous requests from shareholders for information, AVO stuck rigidly to the story that the development of LIGHT was on track and continued to maintain that fiction until well into 2017 when they issued the current schedule.

During that three year period they entered into contracts that they could never fulfil within the timescales that their customers required and accepted money for those contracts. As a result, they lost the contracts, their negotiating agents and had to return the cash despite maintaining that they had no obligation to refund it.

On the strength of AVO's unfounded claims of success and progress, the share price climbed to 400p and then collapsed to 10p when the facts became known.

There is a lot more to the story that current shareholders seem unaware of but the consequences are that AVO's credibility is damaged and it is difficult to see how, for example, the important Chinese market can be recovered.

This is not the stuff of shareprophets. It is the result of hard lessons learned from direct experience of the poor management of the company and their track record of misleading shareholders.

The main lesson learned is to be very sceptical of all statements made by AVO's BoD.

I am sure that the BoD, the main shareholders and the company's creditors will protect their own interests but if I would not be confident that they would look after the interests of anyone else.

All imho, of course. DYOR.

[marvin66] 01/10/2017 00:36

Smells of shareprophets in here...

[johnjohntaylor] 01/10/2017 00:16

Makeamillion: You talk the most sense here. Long term as I expected. Keep the comments flowing it's appreciated to follow someone so knowledgable here. ATB

[johnjohntaylor] 30/9/2017 23:30

Evening all. I fully disagree. There were problems of course, it's a long term project. Not aimed at the short term or less courageous investor but those interested in patience and 'long term' gain.

[daijavu] 30/9/2017 23:11

I fully agree with Sweet Karolina's assessment of the situation.

[daijavu] 30/9/2017 23:08

Three years ago AVO said that they would be treating their first patient by the end of this year. They kept saying that until the beginning of this year when they were forced to admit they were three years behind schedule. They only admitted it several months after LIGHT was supposed to be fully developed after having given repeated assurances to shareholders that development was on track. Until that moment they kept claiming that they were on schedule whenever shareholders asked.

That fact alone should serve as a warning to would be investors.

[mrtruth1] 30/9/2017 21:41

Ridiculously negative. You are massively wrong IMO.

[sweet karolina] 30/9/2017 21:11

The Swedish loan is just positioning them to take the company cheap in a pre pack in my view. They will allow the financial hole to deepen, maybe providing another small short term loan so the development can get a bit further and when they are ready it will be game over for other shareholders.

[mrtruth1] 30/9/2017 19:37

Sweet Karolina: *want

[ileeman] 30/9/2017 17:49

Bought some Friday as chart is breaking out.

[wi1l] 30/9/2017 17:29

And I don't think there is any mention of raising funds via a further placing or even the possibility of one occuring but apparently that would have to be at 25p per share or above and surely they can't be waiting for the price to go up enough for that to be an option? So I suppose the funding route is a long term loan.

[wi1l] 30/9/2017 17:16

Well said - there appear to be some over optimistic views of the future prospects of AVO. However, without the appropriate funding in place (and soon) the company will just end up in the hands of the administrators and sold on for next to nothing with the shareholders being left high and dry.
I just wonder too if it is the Swedish investors who are going to provide long term finance why it is taking so long to organise as it was them who stepped in with the recent loan, but that was back in July which means possibly 4 months has gone by and all we have seen is a few comforting words in the interim accounts that the long term finance will be achieved. Nothing factual which I find mystifying.
re receivables I think these relate to a VAT refund poss quite a large one and prepayments the diff although what they relate to I am not sure.

[sweet karolina] 30/9/2017 16:24

Nope I will continue to express my views on this company and continue to challenge people who what to mislead investors with clear misinformation.

[baner] 30/9/2017 16:14

Sweet Karolina

Go back to bed and pull a blanket over your head. You are just jealous - try to see the bright things in life! It is FANTASTIC that this company will soon be able to launch a system that will be able to save thousands and thousands of lives, at a reasonable cost. This technique will be worth billions in a longer term perspective - the major question today is how AVO can avoid diluting excisting shareholders until they reach their operational goals. A predator would today clearly have to pay more than 50p/share for this and in a competetive situation we will no doubt see 100p+ on the table.

[sweet karolina] 30/9/2017 15:43

makeamillion,

The technology has not been proved over many years by ADAM and CERN, that is why they are going through a very expensive step by step proving programme which is taking far longer than originally envisaged.

They do not have approved funding lines that have not been drawn down, that is why they did the Bracknor death spiral and have put up the only real assets as security for an expensive short term loan from Blackfinch.

Maybe the Swedes do have deep enough pockets to see this through maybe not, but if they have then they will take outright ownership in return for providing it.

THALES are not preparing 2 production lines.

They will not be treating any cancers this time next year, the earliest they might treat a patient is 2020.

Are you deliberately misleading people? or are you really so illiterate that you really do not understand the information the company has provided?

[wi1l] 30/9/2017 10:54

Seems to me that the key to their financial future revolves around these Swedish investors. The co has jettisoned Bracknor who could have lent them up to £52M and in its place set up the £3.9M loan with the Swedish investors probably as a temporary measure to keep the ball rolling. Have a feeling the next funding will be significant and not so short term but they aren't half leaving it to the last minute to organise IMHO. Lets hope they are along way down the road to agreeing terms and details will become clear in the next couple of months.

[makeamillion1] 30/9/2017 09:46

Baner

I agree with your 3960 post thanks to those that have run down the company I significantly bought.

This is one of my largest holdings and the most likely to have a further VIOLENT increase in price within the next couple of months IMHO.

As has been articulated by many already the company is backed by some seriously renowned and wealthy investors IMHO they will not let this company fail.

The accelerator technology the company is using to build LIGHT has already been proven by ADAM & CERN over many many years, as the company has informed investors the technical challenges have largely also been de-risked, the hardest and riskiest stage of the LIGHT development was accelerating the proton beam to 5 MEV from then on it gets easier as all the components are brought together....it is like building a rocket engine now, oh and the manufacturer Thales is an expert in building those as well and is preparing two LIGHT production lines!

Reading the Half Year Report the CEO believes the company is in a much stronger position due to the technological developments to date and importantly regarding financing options says they have been "encouraged by positive feedback".

So IMHO and based on previous requirements to raise funds and the likely cash burn the company needs to announce within the next month a long term funding solution. Initially I thought and hoped to some extent this would have been an open offer but after reading the Half Year Report I am more inclined to believe this will not be the case.

Those that continue to believe the company is insolvent need to understand company law and corporate finance. The company has already informed the market they have sufficient funding in the current year and we also know of approved lines of credit that have not been drawn yet. The Segulah consortium have much at stake and would also not let IMHO the company ever get into an insolvent position.

When the long term funding option materialises and with the company currently on track on every front, one only needs to see where the share price has come from to realise where it could go when they are treating superficial cancers by this THIS TIME NEXT YEAR. This will be the most important milestone IMHO, it will be from this point orders will accelerate, it will be from this point we see a working model, it is from this point analyst forward valuations significantly change. Then Harley Street and other potential clinics will help fuel the acceleration.

There are few investments that have the opportunity to help so many and improve your wealth so much also. DYOR Good luck all.

[dave4545] 30/9/2017 01:28

Bracknor drove this down from 62p now it's having a perfect bowl formation
back to 50p